Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: real-world experience from a cancer center

Haematologica. 2024 Jul 1;109(7):2326-2330. doi: 10.3324/haematol.2023.284565.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / genetics
  • Female
  • High-Throughput Nucleotide Sequencing* / methods
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Lymphoma, Large B-Cell, Diffuse* / genetics
  • Male
  • Middle Aged

Substances

  • Biomarkers, Tumor